GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kainos Medicine Inc (XKRX:284620) » Definitions » Additional Paid-In Capital

Kainos Medicine (XKRX:284620) Additional Paid-In Capital : ₩110,116.5 Mil(As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Kainos Medicine Additional Paid-In Capital?


Kainos Medicine's quarterly additional paid-in capital stayed the same from Sep. 2023 (₩110,116.5 Mil) to Dec. 2023 (₩110,116.5 Mil) and stayed the same from Dec. 2023 (₩110,116.5 Mil) to Mar. 2024 (₩110,116.5 Mil).

Kainos Medicine's annual additional paid-in capital increased from Dec. 2021 (₩84,564.2 Mil) to Dec. 2022 (₩110,116.5 Mil) but then stayed the same from Dec. 2022 (₩110,116.5 Mil) to Dec. 2023 (₩110,116.5 Mil).


Kainos Medicine Additional Paid-In Capital Historical Data

The historical data trend for Kainos Medicine's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kainos Medicine Additional Paid-In Capital Chart

Kainos Medicine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 55,532.58 71,602.34 84,564.20 110,116.53 110,116.53

Kainos Medicine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102,366.95 110,116.53 110,116.53 110,116.53 110,116.53

Kainos Medicine Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Kainos Medicine Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Kainos Medicine's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Kainos Medicine (XKRX:284620) Business Description

Traded in Other Exchanges
N/A
Address
16, Daewangpangyo-ro 712 beon-gil, 4th Floor, Institut Pasteur Korea, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13488
Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.

Kainos Medicine (XKRX:284620) Headlines

No Headlines